All People News articles – Page 8
-
NewsEuropean capacity for antibiotic R&D requires long-term funding
The AMR Accelerator projects have called for long-term investments, stressing the need to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections.
-
NewsEradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
NewsFleming Initiative raises first £100m in the global fight against AMR
Three new partners have pledged additional funding and resources to the Fleming Initiative’s global effort to combat antimicrobial resistance (AMR), as leading medical expert Professor Lord Ara Darzi calls for tighter restrictions on the use of antibiotics.
-
NewsScientist studying parasite-derived vesicles in babesia virulence and vaccine development
Fatah Kashanchi, Professor of Virology at George Mason University, has received funding for the study: ’Parasite-Derived Vesicles in Babesia virulence and Vaccine Development’.
-
NewsResearchers awarded $3 million grant to explore gut health
A $3 million grant has been awarded to investigate the energy generating processes of gut Bacteroides and how they impact our well-being.
-
NewsJordan becomes first country to receive WHO verification for eliminating leprosy
The World Health Organization (WHO) has congratulated the Hashemite Kingdom of Jordan for becoming the first country in the world to be officially verified as having eliminated leprosy.
-
NewsCall for urgent, high-level action to address global scourge of antimicrobial resistance
The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79).
-
NewsResearchers push ambitious 1–10–100 unifying goals on antimicrobial resistance ahead of crucial UN meeting
Researchers have shared their goals of using a One Health-approach to save 10 million lives and aim for 100 per cent sustainable access to effective antimicrobials in a new policy paper ahead of a UN high-level meeting in New York later this month.
-
NewsScientists team up to track gut-brain connection in athletes with concussion
120 athletes are to take part in a concussion study with researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging cannot.
-
NewsCall for global gender-neutral HPV vaccination by 2030
A new global initiative is calling for a more ambitious, ethical and equitable approach that will see more boys and men gain access to cancer-preventing Human Papillomavirus (HPV) vaccination and protect more people worldwide from HPV-related cancers.
-
NewsLarge-scale study will seek to unearth causes of persistent symptoms of Lyme disease
Researchers have received $20.7 million grant to try to answer some of the most vexing questions around chronic Lyme disease, following patients from their earliest diagnosis to find out why some go on to develop debilitating symptoms later on.
-
NewsNIH releases mpox research agenda
National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has released an update on its priorities for mpox research, which focus on four key objectives.
-
NewsScientists team up to create synthetic process for antibiotic drug discovery
Researchers will team up to explore and develop a novel platform or chemical process for synthesizing antibiotic compounds, thanks to a $125,000 grant.
-
NewsResearchers investigate bunyaviruses and picornaviruses in bid to stave off next pandemic
A $13 million per year grant will enable researchers to accelerate their investigations of bunyaviruses, which include life-threatening respiratory and hemorrhagic fever viruses, and picornaviruses, notably enterovirus D68.
-
NewsScientists awarded $90m to prep for future pandemics from understudied viruses
Scientists are laying the groundwork to rapidly respond to potential future pandemics caused by viruses from five understudied families, developing strategies and tools to produce vaccines and antibody-based therapies.
-
NewsSurvey finds epidemiologists believe viral and mosquito-borne pathogens are priority concerns for disease outbreaks
A new survey reveals that infectious disease experts point to viral pathogens and mosquito-borne pathogens as likely to spark outbreaks as humans, animals and viruses overlap; and new viruses are as concerning as changes to existing viruses.
-
NewsX.J. Meng receives prestigious MERIT Award to study hepatitis E virus
The Meng Lab will receive about $2 million over the next five years with the opportunity to seek approval to renew without undergoing regular peer review for five more years for up to $2.4 million, as the lab continues its cutting-edge research on hepatitis E virus.
-
NewsFred Hutch launches Atlas of Inspiring Hispanic/Latinx Scientists
To highlight and celebrate the many contributions of Hispanic and Latinx scientists, Fred Hutch Cancer Center has launched an Atlas of Inspiring Hispanic/ Latinx Scientists.
-
NewsWyss Institute selected to develop biologically engineered broad-spectrum antimicrobial therapeutic
The Wyss Institute for Biologically Inspired Engineering at Harvard University received a contract for up to $12M from the new SHIELD program which aims to develop a prophylactic treatment that can rapidly clear multiple bloodborne bacterial and fungal pathogens.
-
NewsCalls for more action to support vaccine uptake as new data shows two in three older people prioritise vaccine safety
A new report shows that overall trust in vaccines remains high among 50–70-year-olds but stresses more must be done to reach underserved communities and raise awareness about the risks posed by infectious respiratory illnesses.